Thaire Life Assurance PCL (BKK:THREL) Research & Development: ฿0 Mil (TTM As of Mar. 2026)


BKK:THREL Thaire Life Assurance PCL BKK:THREL
43 GF Score
Price ฿0.99
GF Value ฿0.99
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Thaire Life Assurance PCL Research & Development?

Thaire Life Assurance PCL BKK:THREL -1.00% 43 Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus rates BKK:THREL with a GF Score™ of 43/100 and a GF Value™ of ฿0.99 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Thaire Life Assurance PCL's Research & Development for the three months ended in Mar. 2026 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0 Mil.


Thaire Life Assurance PCL  (BKK:THREL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Thaire Life Assurance PCL Research & Development Related Terms


Thaire Life Assurance PCL Research & Development Historical Data

* Premium members only.

The historical data trend for Thaire Life Assurance PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thaire Life Assurance PCL Research & Development Chart

Thaire Life Assurance PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Thaire Life Assurance PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:THREL
43GF Score
Thaire Life Assurance PCL BKK:THREL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thaire Life Assurance PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0 Mil mean?
Thaire Life Assurance PCL (BKK:THREL) has a Research & Development of ฿0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Thaire Life Assurance PCL and its competitors.
Is Thaire Life Assurance PCL's Research & Development too high?
Thaire Life Assurance PCL's current Research & Development is ฿0 Mil. Overall, Thaire Life Assurance PCL has a GF Score™ of 43/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thaire Life Assurance PCL's Research & Development compare to RGA and EG?
Thaire Life Assurance PCL's Research & Development of ฿0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Thaire Life Assurance PCL and its competitors. Thaire Life Assurance PCL's current Research & Development is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thaire Life Assurance PCL stock overvalued right now?
Based on GuruFocus' analysis, Thaire Life Assurance PCL (BKK:THREL) is currently considered Fairly Valued. The stock's GF Value™ is ฿0.99, compared to a current price of ฿0.99 — trading right at its estimated fair value. The current Research & Development is ฿0 Mil. Thaire Life Assurance PCL's overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Thaire Life Assurance PCL (BKK:THREL), the current Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thaire Life Assurance PCL (BKK:THREL) Overvalued in 2026?

Based on GuruFocus' analysis, Thaire Life Assurance PCL stock appears to be undervalued. The current stock price of ฿0.99 is trading 0% below its estimated GF Value™ of ฿0.99. GuruFocus considers Thaire Life Assurance PCL to be Fairly Valued.

Key valuation signals for BKK:THREL:

  • Research & Development: ฿0 Mil
  • GF Value™: ฿0.99 vs. price of ฿0.99 (0% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the BKK:THREL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thaire Life Assurance PCL Business Description

Address North Sathorn Road, No. 92/7 Sathorn Thani 2 Building, 6th Floor, Silom Sub-district, Bang Rak District, Bangkok, THA, 10500
Thaire Life Assurance PCL is a local reinsurer in Thailand. The company is engaged in the provision of life reinsurance services such as ordinary life, group life, credit life and personal accident and health. It operates through the Conventional and Non-Conventional product segments. The conventional product line includes products that are already available in the market. The non-conventional products refers to new types of products, which are introduced by the group in cooperation with other life insurance companies. Geographically the activities are functioned through Thailand.
43GF Score

Get the complete analysis for BKK:THREL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.99
Price
฿0.99
GF Value